RecruitingPhase 2NCT05265208

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Studying Cholangiocarcinoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Center Eugene Marquis
Principal Investigator
Julien Edeline, MD, M.D
Centre de Lutte contre le Cancer Eugène Marquis
Intervention
Capecitabine(drug)
Enrollment
62 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2030

Study locations (7)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05265208 on ClinicalTrials.gov

Other trials for Cholangiocarcinoma

Additional recruiting or active studies for the same condition.

See all trials for Cholangiocarcinoma →

← Back to all trials